The Global Nucleic Acid Labeling Market is projected to grow at a CAGR of 8.4% from USD 1,878.8 Million in 2020 to USD 3,571.9 Million in 2030. The growing demand for personalized medicine has created enormous opportunities in the field of genetic medicine, and, to take advantage of this, new technologies will be developed, resulting in a rapid expansion of the market for nucleic acid or DNA & RNA labeling.
Other factors adding to market growth include the intensification of genomic and enzymatic research and advances in synthetic genome design tools. However, despite significant progress in labeling techniques, the high cost and complexity of the techniques remain a major obstacle to the growth of the global market. Additionally, buying custom nucleic acid probes remains very expensive. Also, procedures such as purification and modification of oligonucleotides, required in most hybridization reactions, can generate additional costs. These factors are expected to hinder the market during the forecast period.
DNA labeling or RNA labeling market consist of many aspects that are widely being research and discussed amongst the players and consumers in the market. 5′ end labeling DNA, radioactive molecule used to label DNA, RNA labeled, nucleotide, nucleotide structure, DNA nucleotides, DNA labeled, DNA structure labeled, labeling DNA molecule, DNA replication, DNA structure and function, T4 DNA Ligase are some of the most concerned topics that the players in the market work on. Labeled nucleotides are supposedly incorporated by a number of different methods including in vitro transcription with the SP6, T7 or T3 RNA polymerase.
Request a Sample@ https://qyresearchmedical.com/sample/118999
Different research applications may require different nucleic acid label densities for optimal performance. Nucleic acids or DNA & RNA can be modified with tags for detection or purification. The obtained nucleic acid probes can be used to identify or recover other interacting molecules. Common markers used to generate nucleic acid probes include radioactive phosphates, biotin, fluorophores, and enzymes. The minimum order quantity of modified oligonucleotides is generally much higher than that of unmodified versions and may be excessive in relation to the amount required for the intended application. For this reason, many researchers may choose internal methods or marking kits for probe generation.
In-depth knowledge of the enzymology involved in the biosynthesis and degradation of nucleic acids has led to the development of simple methods for labeling RNA and DNA with radioisotopes or biotin. Manufacturers are adopting strategies like partnerships, expansion, and acquisition to increase their market share. For instance, ENZO Biochem signed a Supply and Distribution Agreement with Cancer Genetics Enzo Fluorescent Dye Labels to be incorporated with CGI’s DNA Fish Probes. Additionally, increased adoption of nucleic acid labeling technique in a wide range of applications including immunohistochemistry, in situ hybridization, immunofluorescence, western blotting, DNA or RNA blotting, and many others are expected to drive the market for nucleic acid in the coming years.
Technique Type Outlook:
The market for PCR Technique type segment is expected to reach USD 953 Million by year 2027, growing at a CAGR of 8.4% during the forecast period
Random Primer was valued at USD 284 million in 2019 and is expected to grow at the largest rate of 9.7%. Increasing research and development Expenditure is the primary factor contributing to the market growth of this product segment
Product Type Outlook:
As of 2019, Reagents & Kits is the dominating Nucleic Acid Labeling which holds 53.2% of the global market. European regional market is the prominent revenue generating source for this product segment, followed by North America, Asia-Pacific and, other regions.
Services Product Type segment is expected to be the fastest growing market segment during forecast period 2020-2027 with a CAGR of 9.1%. However, Fierce competitive structure of Nucleic Acid Labeling market is a major challenge for the market growth of this market segment.
Regional Outlook:
Asia-Pacific regional segment of the Nucleic Acid Labeling market is expected to remain highest growing segment during 2019-2027, at a CAGR of 10.1%; owing it to the untapped market potential offered by Nucleic Acid Labeling Market in developing nations such as China & India. Europe is anticipated to hold 28.3% of market share by year 2027, and the regional segment is further anticipated to grow at a CAGR of 8.3% throughout the forecast period.
Market-O-Nomics
- Launch of advanced products and systems is expected to support the market growth during coming years. For instance, Agilent’s Next Generation Sequencing (NGS) automation solutions help analysts increase sample preparation throughput without impacting data quality.
- There are promising products for Nucleic Acid Labeling in the making. The anticipated launch of these is likely to support the market growth during forecast period. For instance, in February 2019 NanoView Biosciences Inc. launched its first product, the ExoView platform, to enable the accurate identification and characterization of exosomes.It is the first commercially available product able to provide high-resolution sizing, counting, and phenotyping of exosomes at the individual vesicle level.
- Nucleic Acid Labeling are majorly sold over the counter across the globe. Lack of skilled professionals is a major challenge for the market growth across the globe
- Fierce competitive structure of Nucleic Acid Labeling market is one of the major challenges to the market growth.
- The hospitals end use segment is expected to register a CAGR of 8.4% during 2020-2027.
Companies considered and profiled in this market study
Promega Corporation, Thermo Fisher Scientific, Inc., General Electric Company, New England Biolabs, PerkinElmer, Inc., F. Hoffmann La-Roche AG, Vector Laboratories, Merck KGaA, Enzo Biochem, and Agilent Technologies, among others are leading players involved on the global Nucleic Acid Labeling market.
Start-up Traction
The Nucleic Acid Labeling Market industry poses significant amount of opportunities for small manufacturers and startups to come up with cost-effective solutions in the manufacturing of Nucleic Acid Labeling products. Many innovative start-ups that are growing remarkably have been profiled in the report with all their innovative techniques and developments. There is a continuous growth in demand from the end-users, which can encourage several startups to launch innovative products in this market.
Deals Landscape
Mergers and Acquisitions are an integral part of this industry. These mergers and acquisitions help us decide the strategic initiatives taken up by the leading players as well as growing companies dealing in this market, and have been included in this report.
Expert Insights:
Reports and Data forecasts in the Nucleic Acid Labeling industry having considered the interviews with some of most the prestigious personalities and experts in this market. DNA labeling or RNA labeling market consist of many aspects that are widely being research and discussed amongst the players and consumers in the market. 5′ end labeling DNA, radioactive molecule used to label DNA, RNA labeled, nucleotide, nucleotide structure, DNA nucleotides, DNA labeled, DNA structure labeled, labeling DNA molecule, DNA replication, DNA structure and function, T4 DNA Ligase are some of the most concerned topics that the players in the market work on. Labeled nucleotides are supposedly incorporated by a number of different methods including in vitro transcription with the SP6, T7 or T3 RNA polymerase. The main players, according to experts, need to review their strategies in order to support the following COVID 19 scenario and to maintain healthy relationships with their business partners. As a result of this pandemic, the world’s average disposable income would decrease. The main manufacturers of the company are expected to attempt to discover new areas.
Segments covered in the report
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2020 to 2027. The scope of the report can be defined as:
For the purpose of this study, Reports and Data have segmented the Nucleic Acid Labeling market on the basis of Product type, Technique type, Label type, end use, and region:
Product Type Outlook (Revenue: USD Billion; 2019-2030)
- Reagents & Kits
- Services
Technique Type Outlook (Revenue: USD Billion; 2019-2030)
- PCR
- Nick Translation
- Random Primer
- In Vitro Transcription
- Reverse Transcription
- End Labeling
Treatment Type Outlook (Revenue: USD Billion; 2019-2030)
- Prophylactic
- On-Demand
Label Type Outlook (Revenue: USD Billion; 2019-2030)
- Biotin-based
- Fluorescent
- Radioactive
End Use Outlook (Revenue: USD Billion; 2019-2030)
- Hospital
- Clinic
- Others
Regional Outlook (Revenue: USD Billion; 2019-2030)
- North America
- U.S
- Canada
- Europe
- Germany
- U.K
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of APAC
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
- Latin America
- Brazil
- Rest of LATAM
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/118999/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/